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Accepted 7 September 2017Background: Ejection fraction (EF) is commonly applied as a clinically relevant metric to assess ventricular func-
tion. The numerical value of EF depends on the interplay between end-systolic volume (ESV) and end-diastolic
volume (EDV). Remarkably, the relative impact of the two constitutive components on EF received little atten-
tion.
Methods: Three patient groups not using beta-blockers were analyzed for a robust investigation into the relative
contribution of ESV and EDV when assessing EF: cardiac patients (N = 155) with left ventricular (LV) data ob-
tained by biplane ventriculography, near-normals (N = 276) by gated SPECT investigation, and an MRI-based
post Fallot repair study including right ventricular (RV) data (N= 124), besides LV.We compared various routes
to evaluate EF via linear and several types of nonlinear regression with ESV as independent variable. Advanced
statistics was applied to evaluate sex-speciﬁc differences.
Results: In all cases ESV emerges as the dominant component of EF, with less (P b 0.0001) impact of EDV. The re-
lationship for EF versus ESV is nonlinear (P b 0.0001), and similar for both sexes. A linear approachmay be inad-
equate and generate erroneous statistical outcomes when comparing subgroups of patients.
Conclusions: Values for EF primarily depend on ESV, both for LV and RV. This relationship is essentially nonlinear,
and similar for both sexes. A logarithmic approximation is convenient and often acceptable. However, application
of linear regression for EF vs ESV may lead to incorrect conclusions, particularly when comparing males and
females.
© 2018 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Remodeling
Right ventricle
Ventricular volume regulation
Statistics
Ejection fraction
Sex-speciﬁc analysis
Nonlinear regression
End-systolic volume1. Introduction
Traditionally, the cardiac performance index ejection fraction (EF)
has been widely applied to assess the severity of cardiac disease [1–3].
Typically, a low value of EF corresponds with serious cardiac problems
and a poor prognosis, although this may not apply to all types of heart
failure (HF) [4]. Themajority of clinical trials concentrate on EF as a cen-
tral metric, yet without systematic attention to the relative role of the
constituent components. EF is essentially composed of the ratio of twoll aspects of the reliability and
ed interpretation
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land Ltd. This is an open access articlventricular volume determinations. Calculation of EF is carried out by
taking “one” minus the ratio of two volume determinations, namely
end-diastolic volume (EDV), and end-systolic volume (ESV). Thus:
EF ¼ 1− ESV=EDVð Þ ð1Þ
This procedure yields a dimensionless number, usually expressed as
a percentage (theoretically ranging from 0 to 100%), and applies to both
left ventricle (LV) and right ventricle (RV). Clearly, EF depends on the
“balance” between ESV and EDV, and this notion is explored in the pres-
ent study. The calculation of EF is attractive from a practical point of
view, but unfortunately entails shortcomings [3–4]. Note that many
{ESV, EDV} combinations can generate identical outcomes for any par-
ticular value selected for EF [3].
The few publications available on the subject document an inverse
nonlinear relationship between EF and ESV in cardiac patients [5–6]. Ae under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lines as a sensitive (Pb 0.001) indicatorwhen comparing survival in two
patient groups [7]. In fact, various strategies have been explored to re-
late EF to ESV. Initially, a linear trajectorywas describedwhile excluding
the asymptotic region in the lower EF range [5]. It was shown that the
correlation for EF vs ESVi (i.e. indexed (i) for body size) regarding pa-
tients (N = 113) using beta-blockers (BB) is signiﬁcantly (P b 0.02)
lower than in controls (N= 49). Subsequently, an analytical expression
was derived, showing an inverse nonlinear relationship [3,6]. However,
further progress was hampered by the fact that no statistical tool was
available to compare the analytically derived nonlinear regression
lines.Without any attempt for justiﬁcation of a particular choice regard-
ing the regression model, most studies persisted in using the linear ap-
proach for the full clinically relevant spectrum [7–11]. Three major
shortcomings of the linear approximation refer to the fact that (i) the
theoretical point where EF reaches 100% for small ESVi values is not
respected; (ii) the asymptotic range at lower EF values is not adequately
incorporated; (iii) thus far the intrinsic nonlinearity of the intermediate
range is insufﬁciently acknowledged. The present paper copes with all
these issues, and in addition describes the statistical tools required to
compare these robust nonlinear regression curves.
A few investigators recognized the nonlinear nature and looked at
logit (EF) vs log (ESVi) [12], an exponential ﬁt [13], or EF vs log10
(ESVi) [14]. Some isolated studies have related EF to ESVi for the RV
[15] butmostly in associationwith the tetralogy of Fallot [16] and apply-
ing Spearman ranked correlation [17]. None of these studies compared
various regression models, nor gave attention to possible interaction
with medication reportedly prescribed to a portion of their study
group. The latter aspectmay be clinically relevant, in view of document-
ed differences associated with the use of BB [5].
This study is the ﬁrst to present a statistical tool to compare robust
nonlinear regression curves for EF vs ESVi. Applying the newly devel-
oped strategy to patient groups not using BB allows us to explore and
compare various routes to evaluate EF in dependence upon ESV and
EDV. In line with current guidelines we will also pay attention to sex-
speciﬁc aspects during analysis of the patient data [18].Fig. 1.Volume regulation graph, showing relationship between end-systolic volume index
(ESVi) and end-diastolic volume index (EDVi) for two ranges (25–50, and 50–75 mL/m2,
respectively) of stroke volume index (SVi) in the angiographically evaluated group. The
black line is the identity line. Therefore, the blue and red lines with arrow head reﬂect
average SVi for each group. Triangles refer to average values for ESVi and EDVi in each
group.2. Methods
The elements ESV and EDVwhich contribute to EF can be related [2,3,6] to each other:
ESV ¼ αþ β EDV ð2Þ
and graphically represented (Fig.1) in the volume regulation graph (VRG).
In the past we derived an analytical expression by combining Eqs. (1) and (2):
EF ¼ 1þ γ ESV= δ−ESVð Þf g ð3Þ
with γ= β / R2 and δ= α− EDVave (1− R2) β / R2 where R2 is the variance in ESV ex-
plained by the regression model in Eq. (2), while EDVave is the average value of EDV for
the population under consideration [3,6]. In the present study we compare various routes
to evaluate EF relative to ESV:
i) by obtainingγ and δ fromα, β, R2 via linear regression of ESV on EDV (cf. Eq. (2)), and
then using the formula given by Eq. (3);
ii) by directly estimating the unknown parameters γ and δ in Eq. (3), while using an it-
erative mathematical method for nonlinear regression (see Supplement).
iii) using linear, second order polynomial, and logarithmic analysis.
This retrospective investigation concerns three patient groups not using BB:
1) patients (N= 155) with various types of heart disease as encountered in a represen-
tative major cardiology center. Data on LV volume were collected between 2000 and
2009 at the Cardiovascular Center in Aalst, Belgium, as described in detail before [3].
Brieﬂy, biplane ventriculograms are recorded using a radiographic contrast agent. All
clinical data were primarily obtained for routine diagnostic and treatment purposes,
without any additional procedure related to the present analysis. All patients gave per-
mission to use their data in anonymized investigations by signing a consent form. This
study was exempt from institutional review by the Onze-Lieve-Vrouw Clinic Review
Board.
2) individuals (N= 276) with near-normal LV function or subclinical heart disease. This
group was evaluated by gated myocardial perfusion SPECT in a study between 2001
and 2004, approved by the local Institutional Review Board, and described elsewhere
[14]. Participants had normal perfusion images, normal regional wall motion, and ab-
sence of ECG abnormalities at rest, as well as during stress testing.
3) post Fallot repair patients (N= 124) undergoing RV status evaluation. Volumes were
determined by 1.5 T gated MRI. Also, LV data were available for 121 of these children.
The institutional Review Board approved the retrospective study, with details pub-
lished before [9].
In all patient groups the values for ESV and EDV are normalized to body surface area
(BSA, expressed as m2) to yield corresponding indexed (i) values (ESVi and EDVi, respec-
tively). Similarly we obtained stroke volume index (SVi) and cardiac output index (COi).
Data are analyzed using IBM SPSS version 22 (IBM Corporation, Armonk NY), and
Stata version 12 (StataCorp, College Station TX). Values are presented as average (ave)
values with standard deviation (SD), or 95% conﬁdence interval (CI). It must be noted
that thedirect nonlinear regression (DNR) analysis using Stata follows an independent ap-
proach because comparable (primed) γ’ and δ’ are calculated by DNR on the basis of an it-
erative procedure (Supplement), and not estimated by substituting α and β from Eq. (2).
Values for γ’ and δ’, plus their CI's are presented. Comparison of means is based on two-
sided t-statistics. The Fisher z-transform or the William's test is used to compare R-
differences between groups, as appropriate. Differences regarding regression coefﬁcients
(i.e. slope and intercept) are based on a comparison of pooled estimates and analysis of
variance. Signiﬁcance is considered at the P b 0.05 level.
3. Results
Baseline characteristics for all participating groups are presented in
Table 1, with sex-speciﬁc comparison in Supplement Tables S3 and S4.
The VRG concept is illustrated in Fig. 1 for two subsets with a limited
range of SVi in order to illustrate its linearity.
For the angiographically evaluated patient group we found, using
linear regression:
ESVi ¼ 0:80 EDVi−33:6;R2 ¼ 0:80;N ¼ 155 ð4Þ
with EDVi ave. = 87.6 mL/m2. Thus, α=−33.6 mL/m2 and β= 0.80,
resulting in γ=1.003 and δ=−50.75mL/m2 (Table 1). Following sub-
division in males and females, we obtained two regression lines which
almost coincide. However, the averages for ESVi and EDVi are different,
resulting in signiﬁcantly different average vales for EF (Supplement
Fig. S1A). Similar results were obtained for the other study groups (Sup-
plement Figs S1B and S1C). Supplement Table S1 compares the Pearson
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(Eq. (1)). From the graphical representation in Figs. S1 it can readily
be seen that average EF decreases in a nonlinear fashion when ESVi in-
creases, yielding an asymptotic region for the larger ESVi's as demon-
strated in Fig. 2. For all study groups it appears that ESVi is the
primary determinant of EF. Consequently, it is relevant to investigate
in more detail the precise relationship between EF and ESVi.
Applying Eq. (3), we compared for the three study groups the out-
comes with linear, logarithmic and second order polynomial approxi-
mations (Fig. 2A, B, C). The outcomes are summarized in Table 1, and
indicate that Eq. (3) and logarithmic analysis yield highest correlations,
while the two routes are fairly comparable for the range studied. As a
next step the regression curves for subgroups were investigated to ver-
ify if they are statistically similar or not. We evaluated the sex-speciﬁc
differences for all study groups (Fig. 2A, B, C), plus additional subgroups
based on SVi range (Supplement Table S2), heart failure phenotype
(Supplement Table S6), and survival characteristics as mentioned in
publications elsewhere (Supplement Table S7). To evaluate a method
to identify differences between regression curves for EF versus ESVi in
different groups, we divided the angiographically obtained data into
subgroups with high and low SVi (Fig. 1), deﬁned as 50 b SVi
b 75mL/m2 and 25 b SVi b 50mL/m2, respectively. The traditional linear
approach indicates (Fig. S2) that the two slopes are not different (P =
0.787), in contrast to the intercept (P b 0.001). However, additional
ﬁndings (Supplement Table S7) suggest that the linear approach may
not (always) be correct. In order to more accurately test for differences
between curves the nonlinearmodelwas extended (Supplement Eq. S3)
to include a dummy variable. Supplement Table S7 summarizes ﬁndings
when comparing regression ﬁndings for several subgroups on the basis
of the linear and the robust nonlinear DNR approach. Obviously, appli-
cability of a linearized approximation for EF vs ESVi depends on the spe-
ciﬁc range covered. If the EF-range under consideration is small (as in
the Fallot patients), then a simple linear regression may be justiﬁed
(Supplement Table S5). The same applies to the asymptotic region in
the lower range of EF. However, a nonlinear analysis seems mandatory
when comparing groups covering a wider EF range.
In an earlier study we analyzed EF versus ESVi in patients with heart
failure with preserved EF (denoted as HFpEF), and reduced type
(HFrEF), respectively [3]. The slopes of the linearized regression lines
were compared and found to differ signiﬁcantly (P b 0.0001). Here we
reanalyze those data using the nonlinear approach given in Eq. (3)
while applying the DNR method. The nonlinear regression coefﬁcientsTable 1
Baseline characteristics of all patient groups studied.
Group I Group II Group III (LV) Group III (RV)
N (F %) 155 (41.9) 276 (49.3) 121 (40.5) 124 (40.3)
age (ave ± SD) 65.2 ± 12.1 63.0 ± 9.5 17.4 ± 7.5 17.3 ± 8.5
EDVi (ave ± SD) 87.6 ± 38.4 52.1 ± 25.8 81.5 ± 21.3 147.1 ± 37.6
ESVi (ave ± SD) 38.8 ± 34.5 26.0 ± 23.5 34.5 ± 14.6 77.0 ± 28.2
EF (%) 63.3 ± 19.3 56.1 ± 14.9 58.5 ± 8.5 48.5 ± 9.2
α (value) −33.6 −20.3 −10.8 −29.5
β (value) 0.80 0.89 0.55 0.72
R2 (ESVi vs EDVi) 0.80 0.95 0.71 0.81
γ (value) 1.003 0.9368 0.7746 0.8889
γ’ 1.002 0.9137 0.7869 0.8951
δ (value) −50.75 −22.74 −29.11 −54.34
δ’ −48.12 −21.39 −29.03 −53.54
R2 (EF-ESVi, Eq. (3)) 0.87 0.90 0.64 0.66
R2 (EF-ESVi, ln) 0.85 0.87 0.64 0.66
R2s (EF-ESVi, lin) 0.75 0.77 0.62 0.61
R2 (EF-ESVi, quad) 0.86 0.89 0.61 0.62
R2d (EF vs EDVi) 0.40 0.67 0.12 0.21
P (Rs vs Rd) b0.0001 b0.0001 b0.0001 b0.0001
ave = average; ln = natural logarithm; lin = linear; quad = second order polynomial;
other abbreviations as in Eq. (3). γ’ and δ’ calculated with the use of DNR. R2d (EF vs
EDVi) and R2s (EF vs ESVi) are correlation squared for ejection fraction (EF) versus end-di-
astolic volume index (EDVi), and end-systolic volume index (ESVi),respectively. For male
and female (F) subgroups see Supplement Table S1.(b1 and b2) are not signiﬁcantly different (Supplement Table S6).
Therefore, we conclude that ﬁndings may be incorrect when applying
the linear correlation (Fig. 3).
4. Discussion
Application of the novel statistical tool (coined DNR) described in
this study has shed a new light on earlier studies [7,8,9,11]. The main
ﬁndings concern:
1. An insightful and precise description of an inversenonlinear relation-
ship between EF and ESVi (Eq. (3)), both for LV and RV. Thus, there is
a general tendency for the clinically employed metric of EF to de-
crease if ESVi increases (Fig. 3)
2. The presentation and validation of a robust analytical expression
which relates EF primarily to ESVi rather than to EDVi. The simple ex-
pression (Eq. (3)) is characterized by a few group-associated and
volume-based determinants, namely α, β, and EDVave. These deter-
minants carry a clear physiologic interpretation related to Starling's
law, as shown in the VRG representation (Fig. 1). The VRG may
serve as a building block for subsequent derivations, not only for
the analytical expression concerning EF-ESVi as formulated here,
but also for additional applications such as the estimation ofmyocar-
dial oxygen consumption, again by using α and β (Eq. (2)) [19].
3. By comparing various regressionmodels, the logarithmic approach is
found to offer an acceptable and convenient approximation (Table 1,
Supplement Tables S3 and S4).
4. The linear description as often applied in the past may lead to incor-
rect conclusions whenever regression lines of groups are compared
(Supplement Table S7, Fig. 3). Such studies deserve reinterpretation
on the basis of the present ﬁndings.
5. Average ESVi and EDVi are signiﬁcantly smaller in adult women for
all groups studied, resulting in higher average EF values in females
(Supplement Tables S3 and S4). Data points may be ﬁtted to a single
curve for both sexes (Figs. 2A, 3), but the distributions of the data
points along the curve differ for the two sexes.
6. Obviously, the values for α and βmay slightly differ, depending on
the population studied and the imaging modality applied [20]. Nor-
malization for BSA is common in cardiac dimension analysis, but
body mass, body height, and any suitable allometric relationship
may also be considered. In the VRG representation the data on ab-
scissa and ordinate are always equally indexed, regardless of the
choice (i.e. BSA or similar), implying that the regression equation is
minimally affected by the indexation procedure selected. Obviously,
this is not the case for the EF vs ESVi ﬁgure, because EF is without di-
mension and only ESVi is indexed for BSA. Furthermore, the VRG ap-
proach allows for stratiﬁcation, e.g. on the basis of myocardial mass.
This aspect requires attentionwhen analyzing speciﬁc diagnostic pa-
tient groups. However, the general framework outlined here equally
applies to all patient groups.
7. However, Eq. (3) applies to all modalities, because the formula is
based on a mathematical derivation. Importantly, Eq. (3) adequately
covers the full range of EF values, while there is no single portion of
the curve that is truly linear (Fig. 2A, B, C).
EF is considered a key metric to assess LV function, but according to
recent studies not devoid of important limitations [3,4,21,22]. Since EF
directly depends on ESVi and EDVi, it is of paramount importance to de-
lineate their relative roles. In principle, all relevant combinations can be
evaluated by bivariate analysis, including SVi, ESVi and EDVi. However,
standardized coefﬁcients inmultivariate regression analysis are typical-
ly not that easy to interpret. If independent variables are correlated
(which the large standardized beta for ESVi suggests) it is to some ex-
tent arbitrary to which coefﬁcient the part that can be explained by
both variables is assigned. Justiﬁcation that ESVi is more important
than EDVi can in fact be better demonstrated using William's test for
Fig. 2. A. Ejection Fraction (EF) as a function of end-systolic volume index (ESVi) for the patients with LV disease (N= 155). Actual data points for males and females are presented, along
with their average values andpredicted regression curves based on Eq. (3). B. Ejection Fraction (EF) as a function of end-systolic volume index (ESVi) for the SPECT study. In these cases the
predicted and the logarithmic regression equations yield similar results for R2. Data (N= 276) based on a study by Peace et al. [14]. C. Ejection Fraction (EF) as a function of end-systolic
volume index (ESVi), both for the left (LV) and right ventricle (RV) in post Fallot repair patients. A logarithmic (ln) regression curve has been ﬁtted for each group, illustrating that for the
full range EF values for the RV are higher at identical values of ESVi.
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ing that the relationship between EF and ESVi depends on the value of
EDVi. Statistics document a secondary role for EDVi: ESVi is found to
be superior (see William's test), while additionally EDVi is strongly re-
lated to ESVi (cf. the VRG), meaning that ESVi already incorporates in-
formation that is potentially embodied by EDVi. Indeed, our study
(Table S1) demonstrates that ESVi is the dominant factor for EF in com-
parison to EDVi. We explore and compare various routes to evaluate EFin linear dependence of ESV, aswell as being a nonlinear function of ESV
using the validated robust formula (Eq. (3)). Besides we employ several
other types of nonlinear regression analysis including logarithmic trans-
formation. The ideal description should meet three basic requirements,
namely include the theoretical point where EF approaches 100% for the
hyperdynamic ventricle, provide adequate coverage of the asymptotic
range for larger ESVi values, and a reasonable description of the range
between the two extremes. Our approach adequately incorporates the
Fig. 3.The relationship between ejection fraction (EF) and end-systolic volume index (ESVi) for the left ventricle has often been described by an inverse linear relationship (left panel). This
study shows that a nonlinear approach is more appropriate (right panel), especially when comparing regression curves for various populations, or establishing reference ranges for
subgroups. Here we compare females (N= 136) and males (N = 140).
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paper copes with all three concerns, and in addition offers the statistical
DNR tools required to compare the robust nonlinear regression curves.
When considering a sufﬁciently small range (as e.g. in Fig. 2C) it may
be tempting to employ a linear approximation. Remarkably, the loga-
rithmic regression [14] yields a curve which parallels the robust ap-
proach (Eq. (3)) in a fair manner with similar correlations (Fig. 2A, B,
C). However, when extrapolating the mathematical expression for
each individual case we observe difﬁculties similar as inherent to the
log-logit [12] or exponential approach [13].We conclude that the robust
method presented here carries universal and reliable applicability to the
question at hand, and permits correct comparison of any two
subgroups, for example as based on sex as we have documented. It is
important to emphasize that linear descriptions employed for compar-
ison of two groups [7,11] may imply incorrect conclusions, as exempli-
ﬁed in our study (Fig. 3). Our robust DNRmethod for relating EF to ESVi
is based on the VRG concept [3,6]. A VRG type of presentation for the RV
is also reported in patients with sepsis, but no connection was made
with the expected inverse behavior of the EF versus ESVi relationship
[15].
The linear EF-ESV representation has been advanced as a method to
predict mortality in myocardial infarction patients [7], because the re-
gression lineswere shown to differ signiﬁcantly for two survival catego-
ries. This remarkable ﬁnding has been conﬁrmed in neonates with
congenital heart disease [3]. However, in both cases the analysis was
based on the assumption of a linear approachwhichmay not be univer-
sally applicable, as shown here (Supplement Table S7).
Our ﬁndings have clear clinical implications and provide fundamen-
tal insight into the nature of the metric EF. Interestingly, EF has been
endowed with a central role when quantifying LV performance, mostly
because of the simplicity of its measurement, in particular by current
noninvasive routine clinical work. However, the underlying foundation
remained obscure. More recently the end-systolic elastance (Emax)
concept has been advanced as an alternative candidate to characterize
systolic function of the LV. Interestingly, both metrics clearly depend
on ESV which variable therefore may embody pivotal information.
Unraveling the precise relationship between EF and ESVi is important,because ESVi constitutes themajor determinant of the end-systolic elas-
tance concept [3,6]. Thus, a description of EF in terms of ESVi (Eq. (3))
helps to clarify the connection between the two most popular metrics
of cardiac performance, namely EF and the elastance concept.
A simpliﬁed linear approach to describe EF versus ESVi is not rou-
tinely acceptable, and may provide incorrect results when comparing
patient groups (Fig. 3), and in deﬁning reference ranges [14].
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